Lili Li

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy

It is argued that drug resistance is critically shaped by cancer cell plasticity, which varies widely among patients and contributes to heterogeneous therapeutic efficacy, and a next‐generation precision oncology paradigm integrating stratified diagnosis, rational combination intervention, and adaptive monitoring is proposed.